Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)
Official siteFINANCIAL SERVICES • SHELL COMPANIES • NASDAQ
Market Cap: $141.79M
Last updated: Nov 17, 2026 at 4:00 PM ET
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Statistics
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a market cap of $141.79M and an enterprise value of $140.58M. Its return on invested capital of 27.59% compares with a 14.38% median across 4 similar companies.
Total Valuation
Enterprise value is 0.86% below the market cap, as cash exceeds debt.
| Market Cap | $141.79M |
|---|---|
| Enterprise Value | $140.58M |
| Close (Nov 17, 2026) | $10.72 |
Key Dates
| Last Earnings Date | Aug 12, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is up 1.13% over 52 weeks and trades 0.19% below its 50-day average.
| Beta (1Y) | 0.02 |
|---|---|
| 52-Week Change | +1.13% |
| 1-Month Change | +0.66% |
| 3-Month Change | -0.19% |
| 6-Month Change | +0.19% |
| Total Return (1Y) | +1.13% |
| Return vs SPY (1Y) | -10.33% |
| Max Drawdown (1Y) | -2.56% |
| Sharpe Ratio (1Y) | 0.25 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $10.74 |
| 200-Day Average | $10.70 |
| 52-Week Range | $10.50 to $10.93 |
| RSI (14 Days) | 51.9 |
| Average Volume (20 Days) | 1.83K |
Financial Position
Current assets cover 0.32x current liabilities.
| Current Ratio | 0.32x |
|---|---|
| Quick Ratio | 0.32x |
Returns and Efficiency
Return on invested capital is 27.59% over the last 12 months.
| Return on Assets (ROA) | 2.08% |
|---|---|
| Return on Invested Capital (ROIC) | 27.59% |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$3.36M |
| Pretax Income | $4.34M |
| Net Income | $4.34M |
| Reported EPS (TTM) | $0.27 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $1.23M |
|---|---|
| Total Debt | $11.82K |
| Net Cash | $1.21M |
| Net Cash Per Share | $0.05 |
| Working Capital | -$2.60M |
| Shareholder Equity | -$9.62M |
| Total Assets | $208.21M |
| Total Liabilities | $10.87M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$603.24K |
|---|---|
| FCF Per Share | -$0.05 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
OACC does not pay a dividend.
| Earnings Yield | 2.56% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 8 similar companies, OACC has the 8th highest P/E.
P/E RatioPeer median 44.4x
ROICPeer median 14.38%
| P/E Ratio | 39.0x vs 44.4x median |
|---|---|
| ROIC | 27.59% vs 14.38% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About OACC
What is OACC's market cap?
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has a market cap of $141.79M. Its enterprise value, which adds debt and subtracts cash, is $140.58M.
What is OACC's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has a trailing P/E ratio of 39.0x.
How many shares of OACC are outstanding?
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has 24.58M shares outstanding. The count is up 0.00% from a year earlier.
Does OACC pay a dividend?
No. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share does not pay a dividend.
How much debt does OACC have?
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has $11.82K of total debt and $1.23M of cash and equivalents, a net cash position of $1.21M.
OACC pages: Overview, Statistics, Competitors